Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New study shows possible role of SERMs in future menopausal hormone therapy

06.11.2003


New research published this month in the journal Endocrinology highlights a possible safe, future treatment for postmenopausal women. The research, which was conducted by doctors at Laval University in Quebec, Canada, found that EM-652, a selective estrogen receptor modulator (SERM) given in association with an estrogen, may be effective at controlling hot flashes and preventing breast, uterine and ovarian cancer as well as osteoporosis in postmenopausal women.



Additionally, the combination shows promise in potentially helping with brain function and preventing Alzheimer’s disease with no risk or negative effect.

Over the past year, millions of women have become afraid and confused about the risks and benefits of hormone replacement therapy following the results of the Women’s Health Initiative Study (WHI), which found that women on the combination replacement estrogen and progestin have an increased risk (26 percent) of developing breast cancer. In light of these findings, the medical community has worked to determine the best way to treat the symptoms and risks of menopause, while researchers search for alternative therapies for the millions of women who used combination hormones to treat their menopausal symptoms, such as hot flashes. Dr. Fernand Labrie and his colleagues in Quebec, Canada have now demonstrated that the next generation of menopausal therapy may lie in a combination of SERMs and estrogen, with the SERM preventing the potential risk of breast cancer caused by the estrogen.


Through three separate studies on rats, Dr. Labrie and his team sought to validate the promise of EM-652 as a postmenopausal treatment. The researchers treated different groups of rats with EM-652 and estrogen and measured the impact on the mammary gland and uterus. One study examined the effects of 17beta-estradiol, an estrogen and EM-652 alone and in combination.

The findings showed that when administered together, the estrogen was blocked in the mammary gland and uterus, while EM-652 protected bone and decreased serum lipids. Since EM-652 has little or no access to the brain, it should not prevent estrogen from exerting its beneficial effects on hot flashes, memory and cognition and potentially preventing Alzheimer’s disease. At the same time, EM-652 blocks the negative effects of estrogen in the peripheral tissues, including the mammary gland and uterus.

"EM-652 in combination with estrogen may offer a novel approach to treating postmenopausal women," explained Dr. Labrie. "If our findings in rats are duplicated in women, this tissue-specific hormone replacement therapy could meet the most important needs of women at menopause, which include control of hot flashes, improvement of cognitive function and memory, decreased risk of Alzheimer’s disease and, most importantly, the prevention of three serious cancers-breast, ovarian and uterine-as well as bone loss."

Endocrinology is one of four journals published by The Endocrine Society.

Marisa Lavine | EurekAlert!
Further information:
http://www.endo-society.org

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>